ClinicalTrials.gg
Drug

Serabelisib clinical trials

Also written TAK-117 and MLN1117.

studies test it
13
open now
2
in phase 3
0
first study started
2011

How each study uses serabelisib is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the serabelisib studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Serabelisib
4

Development codes

TAK-117
8
MLN1117
7
INK1117
3
FTH-001
1

Studies by the year they started

13 studies that test it; most in 2016 (3)

Studies that test serabelisib, by start year
YearStudies
20111
20131
20152
20163
20172
20201
20221
20241
20261

By phase

A phase 1/2 study counts in both.

Phase 1
9
Phase 2
7

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 11 · Other 2

Millennium Pharmaceuticals, Inc. (7) · Faeth Therapeutics (3) · Avera McKennan Hospital & University Health Center (1) · Joyce O'Shaughnessy (1) · Petra Pharma (1)

Often tested with

Tested in the same studies.

Sapanisertib (7) · Paclitaxel (2)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses serabelisib is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 13

Codes

What other systems call serabelisib · ClinicalTrials.gg INT000944

  • MeSH (NLM) C000627413serabelisibConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 43J9Q56T3WSERABELISIBConfirmed FDA, NLM, Wikidata
  • Wikidata Q27078071serabelisibConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C98844SerabelisibOne source FDA
  • DrugBank DB14935One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.